Details for Patent: 10,398,785

Which drugs does patent 10,398,785 protect, and when does it expire?

Patent 10,398,785 protects DOCIVYX and is included in one NDA.

This patent has eight patent family members in five countries.

Summary for Patent: 10,398,785

Title:	Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use
Abstract:	Pharmaceutical formulations for parenteral administration comprising taxane compounds complexed with cyclodextrins and polyethylene glycol, methods of making the pharmaceutical formulations and methods of treating cancer patients using the pharmaceutical formulations.
Inventor(s):	William W. Zhao, John K. Thottathil, Denise Smith, Xiaodong Sun, Xiangyu Dong
Assignee:	Meridian Lab
Application Number:	US15/557,212
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 10,398,785

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813-001	Nov 22, 2022		RX	Yes	Yes			Y
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813-002	Nov 22, 2022		RX	Yes	Yes			Y
Avyxa Holdings	DOCIVYX	docetaxel	SOLUTION;INTRAVENOUS	215813-003	Nov 22, 2022		RX	Yes	Yes			Y

International Family Members for US Patent 10,398,785

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
China	107427486
China	111714449
China	111728940
China	111728941
European Patent Office	3270912
Japan	2018512395
Poland	3270912